COMMUNIQUÉS West-GlobeNewswire

-
Immutep doses First Patient in TACTI-002 Phase II Trial
06/03/2019 -
Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference
06/03/2019 -
Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
06/03/2019 -
Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
06/03/2019 -
Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference
06/03/2019 -
Mesa Labs Announces Changes in The Composition of Its Board of Directors
06/03/2019 -
miRagen Therapeutics to Present a Corporate Overview at the 29th Annual Oppenheimer & Co. Healthcare Conference
06/03/2019 -
Catalyst Biosciences Announces Poster Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting
06/03/2019 -
MyoKardia to Present at Cowen & Co. 39th Annual Health Care Conference
06/03/2019 -
Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
06/03/2019 -
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
06/03/2019 -
Cabaletta Bio to Present at the Cowen and Company 39th Annual Healthcare Conference
06/03/2019 -
PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
06/03/2019 -
Biotricity Achieves Significant Milestones for Both Fetal/Maternal and Ambulatory Wellness Monitoring Systems
06/03/2019 -
Misonix To Present At The 9th Annual Canaccord Genuity Musculoskeletal Conference On March 12
06/03/2019 -
GBT Announces New Employment Inducement Grants
06/03/2019 -
Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
06/03/2019 -
Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2019
06/03/2019 -
Tetra Bio-Pharma Names Vice-President, Clinical Programs and Medical Affairs to Its Leadership Team
06/03/2019
Pages